Moleculin Biotech, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2019 – PRNewswire

/ Common Stock Warrants, US Warrant News / By https://commonstockwarrants.com

Moleculin Biotech, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2019 PRNewswire

HOUSTON, Aug. 16, 2019 /PRNewswire/ — Moleculin Biotech, Inc., (NASDAQ: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company …